These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23627242)

  • 1. Compounding slow-release capsules: a comprehensive review and an Excel spreadsheet for faster calculations of excipients.
    Zur E
    Int J Pharm Compd; 2013; 17(1):10-22. PubMed ID: 23627242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounding of slow-release niacinamide capsules: feasibility and characterization.
    Radojkovic B; Milić J; Calija B
    Int J Pharm Compd; 2012; 16(5):434-7. PubMed ID: 23072204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
    Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
    J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories.
    Caraballo I
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1291-301. PubMed ID: 20977292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
    Abd-Elbary A; Haider M; Sayed S
    Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Formulation Excipients and Thermal Treatment on the Release Properties of Lisinopril Spheres and Tablets.
    Amador Ríos Z; Ghaly ES
    Biomed Res Int; 2015; 2015():423615. PubMed ID: 26185757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
    Goole J; Vanderbist F; Amighi K
    Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a robust once-a-day glipizide matrix system.
    Jamzad S; Fassihi R
    J Pharm Pharmacol; 2007 Jun; 59(6):769-75. PubMed ID: 17637169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hydroxypropyl methylcellulose acetate succinate in an enteric polymer matrix to design controlled-release tablets of amoxicillin trihydrate.
    Hilton AK; Deasy PB
    J Pharm Sci; 1993 Jul; 82(7):737-43. PubMed ID: 8360849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
    Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
    Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
    Ku MS; Lu Q; Li W; Chen Y
    Int J Pharm; 2011 Sep; 416(1):16-24. PubMed ID: 21356291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of physicochemical properties of hydroxypropyl methylcellulose (HPMC) type 2208 and their influence on prolonged drug release from matrix tablets.
    Devjak Novak S; Šporar E; Baumgartner S; Vrečer F
    J Pharm Biomed Anal; 2012 Jul; 66():136-43. PubMed ID: 22510313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.